IMC Chicago’s Halozyme HALO Stock Holding History

IMC Chicago’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	20,900 -10,900	-34%	-$743K	﹤0.01%	3273
2026 Q1	$2.06M	Sell	31,800 -221,200	-87%	-$15.6M	﹤0.01%	2549
2025 Q4	$17M	Buy	253,000 +241,800	+2,159%	+$16.3M	0.01%	922
2025 Q3	$821K	Buy	+11,200	New	+$744K	﹤0.01%	2851

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

IMC Chicago's HALO Position: Q2 2026 in Review

IMC Chicago sold out of Halozyme (HALO) in Q2 2026, closing a stake of 13,072 shares — an estimated $891K sold.

IMC Chicago first reported a position in HALO in Q1 2026 and held it in 1 quarter. The position peaked at $845K in Q1 2026. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

IMC Chicago reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 13,072 Halozyme shares in Q2 2026, an estimated $891K.
IMC Chicago first reported a position in Halozyme in Q1 2026 and held it in 1 quarter.
IMC Chicago's Halozyme position peaked at $845K in Q1 2026.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.